Quality Training
Biological Evaluation of Medical Devices, including Chemical Characterization
Full Details
This programme is delivered online over 4 half days from 9am to 13.00pm,Key learning objectives:
· Gain a complete overview of the biocompatibility requirements in the EU and US to ensure compliance
· Examine important parts within ISO 10933 to ensure your device manages biological risk
· Examine the link between biocompatibility and ISO 14971 risk management
· Examine the Medical Device Regulation (MDR) safety requirements in the context of biocompatibility to maintain compliance
· How to plan and undertake a biological evaluation of a medical device
· Detailed understanding of the chemical characterisation and toxicological evaluation
· Explore material characterisation and learn how to characterise novel materials
Benefits of attending:
· Build your Biological Evaluation Plan and create a strategy to meet current ISO 10993-1 expectations.
· Avoid wasted time in the development process by understanding where your biocompatibility gaps are so that you can address them in a timely manner
· Demonstrate to regulatory agencies that the biological evaluation plan was assembled by those with appropriate expertise
· ”Common pitfalls” – avoid the typical mistakes
· Understand biological evaluations to ensure you can outsource effectively and can interpret results
· Learn to interpret the requirements to identify and determine testing end-points
Trainer Details:
Rossella Calò
Rossella Calò joined the Eurofins Group in 2016, immediately focusing on medical devices. She initially held the role of Microbiological Study Director, followed by a position as Project Manager. In 2021, she became part of the Regulatory & Consultancy Services team, where she specializes in Biological Risk Assessments for medical devices.
She is currently a Senior Consultant and Team Leader of the Medical Devices Consulting Team in Italy.
Rossella is skilled in performing biological evaluations and literature reviews to support preclinical data for medical devices, based on normative and regulatory requirements, significantly contributing to the safety and compliance of medical devices
Martina Danesi
Martina has been specializing in biocompatibility since 2021, having started her career at RA Specialist before joining the Eurofins group in 2022. She is currently part of the medical device consultancy team. With a strong background in the field, Martina focuses on preparing biological evaluations and literature reviews to support preclinical data for medical devices. She has successfully completed over 200 biocompatibility assessments, significantly contributing to the safety and regulatory compliance of medical devices.
Content includes
Module 1: Introduction to the course and overview of biocompatibility· What is biocompatibility and why is a biological evaluation needed?
· Examining the ISO 10993 series – biological evaluation
· Examine the impact of the Medical device Regulation (MDR)
· The relation between ISO 10993 and the risk management standard ISO 14971
· Medical device categorization for biological risk assessment
· Medical Device Directive (MDD) safety requirements vs the Medical Device Regulation (MDR) safety requirements
· MDR, FDA and biocompatibility
· Evaluation and testing within a risk management process: Use of ISO 10993-1
· Chemical Characterization and Toxicological Evaluation: Use of ISO 10993-18 & -17
Module 2: Biological evaluation – FAB four
· Biocompatibility testing – Endpoints to be addressed in a biological risk assessment
· GLP requirements
· Lab selection
· FAB FOUR: Cytotoxicity, irritation, sensitisation and acute systemic toxicity
· Endotoxin contamination and material mediated pyrogenicity: US-FDA expectations
· What you should consider in the communication with the test-house
Module 3: Long term toxicity and sample preparation
· Genotoxicity ISO 10993-3 “Tests for genotoxicity, carcinogenicity and reproductive toxicity” & ISO/TR 10993-33 “Guidance on tests to evaluate genotoxicity - Supplement to ISO 10993-3”
· ISO 10993-4: Biological evaluation of medical devices – Part 4: Selection of tests for interactions with blood
· Sample Preparation ISO 10993-12 “Biological evaluation of medical devices -Part 12: Sample preparation and reference materials”
Module Module 4: Chemical Characterization and Toxicological Evaluation: Use of ISO 10993-18 & -17
· Physical and Chemical characterisation as part of material qualification and selection
· Summary of the different steps to be addressed for a proper Extractables-Leachables Screening Study
· Illustration of different study designs which may be applied for complex materials consisting of many different parts
· Overview and selection of chemical testing methods for material characterization and the use of results
· Definition of an appropriate Tolerable Exposure (TE)
· Selection of different approaches to address a toxicological assessment
· Pills on the new version of ISO 10993-17 (ISO/FDIS: Final Draft of International Standard)
· Conclusions and next step after a Toxicological Risk Assessment
Who should attend
Medical Technology ProfessionalsQualification
Certificate of AttendanceUpcoming dates:
Location
Dates
Book now
Course
Biological Evaluation of Medical Devices, including Chemical Characterization
Training Days
4 Sessions
Training Location
Available nationally, based on demand
Course Cost
Subsidised rate: €566
Full cost: €755
* Cost quoted per person